In animal models, although chronic rapamycin treatment from postnatal day 8 to 40 improved anxiety- and depression- like behaviors in a model of Tsc1 [23], daily rapamycin administration beginning at E12.5 resulted in hippocampal-dependent learning impairment in a mice model of Tsc2 [24]. Here, TSC2 is linked to depressive disorder.